Canasa is a Rectal Suppository in the Human Prescription Drug category. It is labeled and distributed by Mckesson Rxpak Inc. The primary component is Mesalamine.
| Product ID | 65084-474_f22429d1-5a9e-4286-a856-8104e188e35e |
| NDC | 65084-474 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Canasa |
| Generic Name | Mesalamine |
| Dosage Form | Suppository |
| Route of Administration | RECTAL |
| Marketing Start Date | 2001-01-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021252 |
| Labeler Name | Mckesson Rxpak Inc |
| Substance Name | MESALAMINE |
| Active Ingredient Strength | 1000 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-01-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021252 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-01-20 |
| Marketing End Date | 2019-09-01 |
| Ingredient | Strength |
|---|---|
| MESALAMINE | 1000 mg/1 |
| SPL SET ID: | 75fb1efa-d513-4203-8962-6508a24ef3eb |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58914-501 | Canasa | Canasa |
| 65084-474 | Canasa | Canasa |
| 0023-5901 | Asacol HD | mesalamine |
| 0430-0783 | ASACOL HD | mesalamine |
| 0023-5853 | Delzicol | mesalamine |
| 0179-0142 | Lialda | mesalamine |
| 0093-5907 | Mesalamine | Mesalamine |
| 0093-9224 | mesalamine | mesalamine |
| 0378-1375 | Mesalamine | mesalamine |
| 0378-9230 | Mesalamine | mesalamine |
| 0472-1915 | Mesalamine | Mesalamine |
| 0037-0066 | Rowasa | mesalamine |
| 0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CANASA 76124724 2595613 Live/Registered |
APTALIS PHARMA US, INC. 2000-09-08 |